Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:20:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and a prior funding notice (v3.4.1) removed; these administrative changes do not affect the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T09:21:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new government funding notice about the NIH Clinical Center operating status has been added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T05:23:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Show glossary option and color-coding explanations have been added to the study history page, clarifying how additions (green) and deletions (red) are displayed. The revision label updated to v3.4.0 and the 'No FEAR Act data' wording was removed in favor of the current phrasing. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T02:30:32.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; no changes to study data or major content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:34:10.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new page revision 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' label were removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:18:46.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.